Bruce Booth bought $1.1M of Sionna Therapeutics (SION)
Executed Feb 10 2025, disclosed Feb 10 2025, the same day.
Over the 21 trading sessions from the disclosed entry session (Feb 10 2025), the stock returned -31.5% (delay-adjusted); from the execution session (Feb 10 2025), -31.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Bruce Booth (Director) filed 16 Form 4 reports in the trailing twelve months (0 purchases, 16 sales, 1 filed past the two-business-day deadline), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $56.3M of KYMR (511,764 sh across 27 lots, as filed), executed Jun 26.
Healthcare · Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibros…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→87,568 sh across 7 lots
Exec Oct 21 2025
Filed Oct 21 2025 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. $9.1M
281,560 sh across 14 lots
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. $5.9M
193,469 sh across 9 lots
Exec Oct 10 2025
Filed Oct 15 2025 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. $1.4M
47,499 sh across 3 lots
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. $2.3M
76,344 sh across 3 lots
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET